Liposomal Bupivacaine With Dexamethasone for Foot Surgery
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
- Status
- RECRUITING
- Phase
- PHASE3
Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study
- Status
- RECRUITING
- Phase
- NA
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury
- Status
- RECRUITING
- Phase
- NA
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
- Status
- RECRUITING
- Phase
- PHASE4
Comparison Between Ketamine Intrathecal and iv Dexamethasone for Post Cesarean Analgesia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
- Status
- RECRUITING
- Phase
- PHASE4
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2